J.Jill JILL 深 沪
等待开盘 08-19 09:30:00 美东时间
20.00
+1.320
+7.07%
华盛通- 最 高20.00
- 今 开18.88
- 成交量 8.99万股
- 最 低 18.355
- 昨 收 18.68
- 总市值 2.99亿
- 52周最高 20.00
- 市盈率 静 11.00
- 换手率 0.60%
- 52周最低 10.225
- 委 比 -9.89%
- 总股本 1495.14万
- 历史最高 65.54
- 量 比 2.35
- 振 幅 8.81%
- 历史最低 0.84
- 每 手 1
- 风险率 1.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
今天 08:37
TD Cowen Maintains Hold on J.Jill, Raises Price Target to $18
TD Cowen analyst Jonna Kim maintains J.Jill (NYSE:JILL) with a Hold and raises the price target from $14 to $18.
08-18 22:26
美股大行评级 | 甲骨文绩后分歧大！5家上调，2家下调；Navan、Hinge Health、凯西通用获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从6美元升至10美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14美元升至14.5美元
06-12 11:32
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Rothschild & Co analyst Simon Clinch downgraded Marketaxess Holdings Inc (NASDAQ:MKTX) from Buy t...
06-11 23:42
William Blair Downgrades J.Jill to Market Perform
William Blair analyst Dylan Carden downgrades J.Jill (NYSE:JILL) from Outperform to Market Perform.
06-11 23:22
电话会总结 ｜ J.Jill(JILL)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据J.Jill业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第一季度总销售额为1.44亿美元，同比下降6%，其中可比销售额下降8.7%。零售销售额下降约4%，直销渠道销售额下降约8%，直销占总销售额的46%。 **利润率表现：** 毛利率为68.3%，同比下降350个基点，主要受470万美元关税成本和更多降价销售影响。总毛利润约为9,870万美元，同比减少约1,200万美元。 **盈利能力：** 调整后EBITDA为1,670万美元，较去年同期的2,730万美元大幅下降。调整后每股摊薄净收益为0.45美元，低于去年
06-11 12:07
美股大行评级 | 高盛上调美光科技目标价从400美元升至900美元；斯马克、Cloudflare获多家公司上调目标价
今日重点评级关注：Ascendiant Capital：维持NextTrip"买入"评级，目标价从7美元升至7.5美元；Maxim Group：维持Zevra Therapeutics"买入"评级，目标价从25美元升至35美元
06-11 09:55
BTIG Reiterates Buy on J.Jill, Maintains $18 Price Target
BTIG analyst Janine Stichter reiterates J.Jill (NYSE:JILL) with a Buy and maintains $18 price target.
06-11 01:10
J.Jill Reports Q1 2026 Results: Full Earnings Call Transcript
J.Jill (NYSE:JILL) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/...
06-10 20:42
Earnings Scheduled For June 10, 2026
Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is likely to report quarterly earnings at $0.39 per share on revenue of $3.35 billion. • J.Jill (NYSE:JILL) is likely to report quarterly earnings at $0.42 per share on revenue of $144.21 million. • Yuanbao (NASDAQ:YB) is estimated to report ea...
06-10 19:11
